<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04379882</url>
  </required_header>
  <id_info>
    <org_study_id>OC32 Silva</org_study_id>
    <nct_id>NCT04379882</nct_id>
  </id_info>
  <brief_title>Feasibility Study Evaluating the Silva Module During the Anaesthesiology Consultation Before an Elective Surgery</brief_title>
  <acronym>Silva</acronym>
  <official_title>Feasibility Study Evaluating the Silva Module During the Anaesthesiology Consultation Before an Elective Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oncomfort</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oncomfort</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this feasibility study, feasibility, acceptability and an initial clinical efficacy of the&#xD;
      new module of Hypnosis and Virtual Reality (or Digital Sedation), Silva, will be evaluated.&#xD;
      This feasibility study meets objectives of Oncomfort's design validation and design&#xD;
      verification steps. Silva will be tested on a sample of 10 patients in the environment where&#xD;
      the product is intended to be used, a hospital environment. If results do not fit with user&#xD;
      needs, design will be adapted according to results and a new phase of design validation will&#xD;
      be implemented. The Silva module is a Digital Sedation module designed for management of pain&#xD;
      and anxiety in perioperative patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be recruited during the anaesthesiology consultation preparing to an elective&#xD;
      surgery.&#xD;
&#xD;
      First, subject will be asked to self-assess anxiety and comfort. In order to evaluate&#xD;
      anxiety, subject will use a 0-10 rating Visual Analogue Scale (VAS) where 0 = no anxiety at&#xD;
      all, and 10= the worst imaginable anxiety. The same scale will be used to measure the level&#xD;
      of comfort where 0 means no comfort at all and 10 very comfortable.&#xD;
&#xD;
      Subject should be positioned laying on a reclining chair during the session. This session&#xD;
      will last for 30 minutes. After the experiment, participants will be asked to rate anxiety,&#xD;
      level of comfort, level of immersion and dissociation.&#xD;
&#xD;
      Several questions will be asked to the patient to evaluate his/ her experience, the Silva&#xD;
      module, and the sensations experienced.&#xD;
&#xD;
      The study will be ended by an evaluation of adverse event (AE) and the evaluation of the&#xD;
      caregivers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Decision of alternative research to be performed&#xD;
  </why_stopped>
  <start_date type="Anticipated">November 10, 2020</start_date>
  <completion_date type="Anticipated">December 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the acceptability and the patient's qualitative reported experience of Silva</measure>
    <time_frame>Day 1 of the intervention</time_frame>
    <description>questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate Anxiety</measure>
    <time_frame>Day 1 of the intervention</time_frame>
    <description>questionnaire VAS 0 (no anxiety)- 10 (max anxiety)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate Comfort</measure>
    <time_frame>Day 1 of the intervention</time_frame>
    <description>questionnaire VAS 0 (extreme discomfort)- 10 (extreme comfort)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of agreeability of the Digital Sedation session</measure>
    <time_frame>Day 1 of the intervention</time_frame>
    <description>questionnaire VAS (0-10) 0: not agreeable, 10: extremely agreeable</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Preoperative Anxiety</condition>
  <arm_group>
    <arm_group_label>Digital sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 minutes Silva module</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Digital Sedation (Silva)</intervention_name>
    <description>Use of Digital Sedation (virtual reality associated with psychological interventions) for preoperative anxiety management</description>
    <arm_group_label>Digital sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        â€¢ Subject more than 18 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Deaf subject&#xD;
&#xD;
          -  Blind&#xD;
&#xD;
          -  Non-proficiency in French (Module language)&#xD;
&#xD;
          -  Psychiatric disorder&#xD;
&#xD;
          -  Head or face wounds&#xD;
&#xD;
          -  Neurological disease&#xD;
&#xD;
          -  Chronic pain and/or chronic analgesics consumption&#xD;
&#xD;
          -  Medication affecting the autonomic nervous system&#xD;
&#xD;
          -  Dizziness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 17, 2020</study_first_submitted>
  <study_first_submitted_qc>May 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2020</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

